Proactive news headlines including Apollo Minerals, Anson Resources, BlackEarth Minerals and Emyria

Written by Customer Service on . Posted in Mergers And Acquisitions.

Sydney, Sept. 01, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

  • Apollo Minerals Ltd’s (ASX:AON) diamond drilling program has delivered further strong zinc-lead intersections at shallow depths that point to a major zinc and lead discovery developing at the Kroussou Project in Gabon. Click here
  • Anson Resources Ltd (ASX:ASN) has delivered an updated preliminary economic assessment (PEA) for stage one of the Paradox Brine Project in Utah, USA. Click here
  • BlackEarth Minerals NL (ASX:BEM) has appointed CPC Project Design as engineering contractor for the definitive feasibility study at its 100%-owned Maniry Graphite Project in southern Madagascar. Click here
  • Emyria Ltd (ASX:EMD) has highlighted promising results from a previously published study assessing the effects of MDMA (ecstasy) and a unique MDMA-analogue (UWA-101) in a Parkinson’s disease (PD) model. Click here
  • Nova Minerals Ltd (ASX:NVA) believes its latest infill drilling results at the 4.7-million-ounce Korbel deposit within the flagship Estelle Gold Project in Alaska pave the way for an updated indicated mineral resource estimate later this year, after demonstrating continuity of mineralisation and scale with high-grade “blow-out” zones. Click here
  • Aurumin Ltd (ASX:AUN) shares surged as much as 75% higher intra-day to 28 cents after receiving high-grade gold assays up to 1 metre at 153.50 g/t gold from drilling at the Mt Dimer Project in Western Australia. Click here
  • Imugene Limited (ASX:IMU, OTC:IUGNF), a clinical-stage immune-oncology company, has revealed secondary efficacy endpoint progression-free survival (PFS) data for its HER-Vaxx immunotherapy in HER-2 positive gastric cancer. Click here
  • Danakali Ltd (ASX:DNK, LSE:DNK, OTC:SBMSF) has thanked Robert Connochie for his contribution to the company after he elected to retire as a non-executive director effective midnight August 31, 2021. Click here
  • Comet Resources Ltd (ASX:CRL) has unsurfaced up to 132 g/t gold during a resampling program on historical drill core from the Santa Teresa Gold Project in Baja California, Mexico. Click here
  • Marvel Gold Ltd (ASX:MVL) has confirmed a shallow, higher-grade parallel lode of mineralisation from a resource expansion drill program at its Tabakorole Gold Project in southern Mali. Click here
  • Miramar Resources Ltd (ASX:M2R) has identified multiple electromagnetic (EM) conductors within the Dooley Downs tenement application, part of the Bangemall Nickel-Copper-PGE Project in the Gascoyne region of Western Australia. Click here
  • Piedmont Lithium Inc (ASX:PLL, NASDAQ:PLL, XETRA:). has completed a 9.9% investment in AIM-listed IronRidge Resources Ltd (AIM:IRR, FRA:BSG) (IRR). Click here
  • Oar Resources Ltd (ASX:OAR)’s drilling at Gibraltar Halloysite-Kaolin Project has returned a composite sample grading 53% halloysite, which the company believes to be the highest grade halloysite observed in any project in Australia. Click here
  • Calima Energy Ltd (ASX:CE1) has tabled its 2021 oil and gas reserve estimates for its wholly-owned Canadian subsidiary, Blackspur Oil Corp. Click here
  • Element 25 Ltd (ASX:E25) has made its second commercial shipment of high-quality manganese concentrate from the Butcherbird Manganese Project in Western Australia’s Pilbara region, marking another milestone in its project development journey. Click here
  • Chimeric Therapeutics Ltd (ASX:CHM) ended FY2021 in a healthy financial position with $22.4 million in cash and equivalents as it moves ahead with its Chlorotoxin CAR T (CLTX CAR T) cell clinical trial. Click here
  • Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF) continues to focus on the expansion of commercialisation activities and revenue generation from its new clinically tested products, with the strategy expected to lead to the launch of a suite of new cannabinoid-based products over FY22. Click here
  • SUDA Pharmaceuticals Ltd (ASX:SUD) has released its preliminary financial report for the 2021 financial year, a period during which the drug delivery company secured Therapeutic Goods Administration (TGA) approval for its ZolphiMist® insomnia treatment. Click here

About Proactive

With six offices on three continents and a team of experienced business journalists and broadcasters, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives engage intelligently with investors.

Proactive’ s platform delivers the right message to the right audience, digitally and in real time, leveraging a range of media, investment research, digital investor targeting and website development services to support over 1,000 fast-growing companies globally.

Proactive’s network reaches over 12 million engaged private, professional and institutional investors looking for opportunities.

  • Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.
  • We syndicate our content to hundreds of mainstream and specialist news sites that expand our reach into networks that can be difficult for press releases to penetrate.
  • We custom build corporate websites from the ground up, empowering clients and their brands with a modern online presence and the latest insight on effective SEO strategy.
  • Our news coverage ranks high on the world’s most popular search platforms, and we can further amplify online presence and outreach with sophisticated digital investor targeting.
  • We help the world understand what makes companies stand out from the crowd with in-depth investment research from a team of experienced analysts.

For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.